v3 Template
G

GeneDx

Healthcare / Genomics not specified ~340 employees
Founded
--
Employees (Est.)
~340
17 leaders known
Total Funding
$450.0M
Funding Rounds
3
Last Funding
2023-01-31

About GeneDx

GeneDx is a leader in genomic diagnosis, specializing in genetic testing for rare and complex conditions. Their mission is to deliver precise, fast, and actionable diagnoses to empower individuals to live their healthiest lives through genomics. They have performed over 2.5 million tests and focus on providing clarity and hope for patients with rare diseases.

Products & Services

Genome Sequencing (GenomeDx™):Comprehensive testing to analyze the entire genome for rare and complex conditions.
Exome Sequencing (ExomeDx™):Focuses on coding regions of over 20,000 genes to identify genetic causes of conditions.
Targeted Variant Testing:Specific testing for known genetic variants related to certain conditions.
Prenatal Genetic Testing:Genetic testing for expecting parents to assess risks for fetal conditions.
Rapid and UltraRapid Testing:Fast genetic testing with results available within days or weeks.
GeneDx Infinity™:A powerful tool leveraging a large rare disease dataset for accelerating diagnoses and drug discovery.

Specialties

Pediatric Neurology General Pediatrics Autism Cerebral Palsy Epilepsy Global Developmental Delay and Intellectual Disability Neurodevelopmental Disorders Neonatal & Pediatric Critical Care

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Underwritten Public Offering and Registered Direct Offering
T: -
FT: Underwritten Public Offering and Registered Direct Offering 		A: 150000000
MR: -
FA: approximately $150 million
FAN: 150000000 		D: 2023-01-31
FD: 2023-01-31 		-
2 RT: Public Offering
T: -
FT: Public Offering 		A: 150000000
MR: -
FA: $150 million
FAN: 150000000 		D: 2023-01-27
FD: 2023-01-27 		3 investors
3 RT: Underwritten Public Offering and Registered Direct Offering
T: -
FT: Underwritten Public Offering and Registered Direct Offering 		A: 150000000
MR: -
FA: approximately $150 million
FAN: 150000000 		D: 2023-01-26
FD: 2023-01-26 		3 investors
Underwritten Public Offering and Registered Direct Offering Latest
2023-01-31
$150.0M
Public Offering 2023-01-27
$150.0M
Underwritten Public Offering and Registered Direct Offering 2023-01-26
$150.0M

View 2 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

K

Katherine Stueland

Chief Executive Officer

B

Bryan Dechairo

Chief Operating Officer

H

Heidi Chen

Chief Legal Officer

J

Jami Biliboaca

Head of People Strategy

K

Kevin Feeley

Chief Financial Officer

L

Linda Genen

Chief Medical Officer

View 14 more team members with Pro

Unlock Full Team Directory

Recent News

GeneDx Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Website
genedx.com
Industries
Healthcare / Genomics
Company Size
~340 employees (est.)
Locations
not specified
Boston, MA
New York City, New York; Miami Beach, Florida

Similar Companies

Discover AI-powered company recommendations based on industry, funding, and team profiles.

Upgrade to Pro

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro